CVS Health Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CVS Health Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 57% of its market value (net debt). Lower than 93% of Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $0 per $100 of sales comes from others' credit, against $1 tied up three years earlier. Less money tied up than 90% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 87% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
3.8×Over the last 3 years its own operating cash covered its investment spending (capex) 3.8 times.
Higher than 82% of Healthcare companies in United States.
Cash Locked Ratio
−$0Money owed to suppliers is larger than money owed by customers plus stock: $0 per $100 of sales comes from others' credit, against $1 tied up three years earlier.
Less money tied up than 90% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$3Sales grew 25% in 3 years, but profit fell: $3 less profit per $100 of extra sales.
Lower than 70% of Healthcare companies in United States.
Asset Productivity Ratio
+25% / +11%In 3 years sales changed by +25% while total assets changed by +11%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.6×Debt due within a year is covered 2.6 times by its yearly operating cash.
Higher than 76% of Healthcare companies in United States.
Cash Cushion Ratio
−57%Debt, after subtracting cash, equals 57% of its market value (net debt).
Lower than 93% of Healthcare companies in United States.
Tangible Assets Ratio
56%Of every $100 the company owns, $56 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 72% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 87% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
CVS Health Corporation owes $0.69 for every $1 it owns. Net profit fell 62% in the year to Dec 2025, and shrank 26% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
24.9Investors pay $24.9 for every $1 of CVS Health Corporation's yearly profit, lower than 54% of Healthcare companies in United States.
P/B ratio
1.52The share price is 1.52 times CVS Health Corporation's book value per share, lower than 67% of Healthcare companies in United States.
Market cap
$120.8 BThe total market value of all of CVS Health Corporation's shares at today's price (share price × number of shares), larger than 98% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$79.7 BWhat CVS Health Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$62.32Net worth divided by the number of shares. The share price of $94.48 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
6.2%CVS Health Corporation earned 6.2% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
Owes vs Owns
0.69×CVS Health Corporation owes $0.69 for every $1 it owns (moderate), higher than 71% of Healthcare companies in United States.
Dividend yield
2.85%CVS Health Corporation pays 2.85% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in United States.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit growth
-62%Net profit fell 62% in the year to Dec 2025, and shrank 26% a year on average over 3 years.
Profit margin
0.4%CVS Health Corporation keeps $0 of every $100 of revenue as net profit.
Cash quality
6.0×Cash from CVS Health Corporation's business was 6.0× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
3.3×CVS Health Corporation's operating profit covered its interest costs 3.3 times in the year to Dec 2025.
Cash vs debt
Net debtCVS Health Corporation had $69.4 B more debt than cash (net debt) at Dec 2025.
Questions
What is CVS Health Corporation's P/E ratio?
Investors pay $24.9 for every $1 of CVS Health Corporation's yearly profit, lower than 54% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CVS Health Corporation: $120.8 B ÷ $79.7 B (30 Jun 2026) = 1.5.
What is CVS Health Corporation's return on equity?
CVS Health Corporation earned 6.2% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
How much does CVS Health Corporation owe compared with what it owns?
CVS Health Corporation owes $0.69 for every $1 it owns (moderate), higher than 71% of Healthcare companies in United States.
Does CVS Health Corporation pay a dividend?
Yes. CVS Health Corporation pays 2.85% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in United States.
Is CVS Health Corporation's revenue growing?
Revenue rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.